PharmaShots | Incisive News in 3 Shots

Subscribe Now

P-III tackle trial

AstraZeneca's AZD7442 Meet its Primary Endpoints in P-III TACKLE Trial for the Treatment of COVID-19

AstraZeneca's AZD7442 Meet its Primary Endpoints in P-III TACKLE Trial for the Treatment of COVID-19

October 12, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us